Isupartob Sodium Earns FDA Fast Track for Sepsis Indication
Fast Track status enables rolling review and closer FDA collaboration — a potential signal for future nutraceutical-adj…
Fast Track status enables rolling review and closer FDA collaboration — a potential signal for future nutraceutical-adj…
The intranasal delivery route could expand non-injectable antiemetic options; human PK data expected by late 2026.
The GSK-3β inhibitor joins a Cancer Research UK-sponsored multi-arm trial after a complete response was recorded in a p…
The placement positions GURU inside one of the natural channel's highest-engagement retail environments as functional e…
The Canadian organic energy brand gains a direct shelf position in one of natural retail's highest-engagement banners a…
With average QSR lunch tickets pushing $15–$20, value-positioned functional wraps are carving a new lane in the better-…
Preliminary durability data presented at the Clinical TMS Society Annual Meeting signal a potential shift in how device…
TG Therapeutics advances to a potential registration-directed Phase 2 trial as subcutaneous delivery format targets imp…
Topline data from the randomized, double-blind LIBERTY study is expected in Q3 2026, alongside results from the pivotal…
Fast Track status shortens FDA review timelines for serious conditions with unmet need — a designation increasingly rel…
Exosome-based delivery systems are emerging as a next-generation carrier technology; analytical validation could reshap…
The Cambridge-Boston biopharmaceutical firm signals a governance upgrade as it pushes first-in-class candidates toward …